Nav: Home

Heart signaling map sheds light on the molecular culprits behind cardiovascular disease

October 10, 2016

Having a big heart is not always a virtue and, from a physiologist's point of view, it can be deadly. An enlarged heart is a hallmark of dilated cardiomyopathy (DCM) and, despite being the most common inherited disease of the heart muscle, doctors don't really know why it occurs. But that could now change as a new University of Toronto study begins to shine light on the molecular causes behind DCM.

Published this week in the Proceedings of the National Academy of Sciences of the U.S.A., the study reveals widespread differences in protein biochemistry between healthy and diseased hearts. This expands our understanding of heart physiology and opens the door for future research that could improve detection and treatment of DCM.

Affecting all ages, the disease begins usually in adolescence and strikes one in five Canadians, with huge healthcare, economic and social costs. It occurs when a normal-looking heart begins to dilate, or stretch, for no apparent reason. This enlarged heart can no longer maintain the normal rhythm and pump the blood around the body, which leads to heart failure. Although we know that DCM is rooted in genetics, its molecular culprits remain poorly understood.

Led by Professors Andrew Emili and Anthony Gramolini, the researchers mapped changes in protein signalling pathways in heart cells that lead to DCM. Emili is member of U of T's Donnelly Centre for Cellular and Biomolecular Research and a Professor of Molecular Genetics, while Gramolini is part of the Ted Rogers Centre for Heart Research, an Associate Professor in Physiology and a Scientist at the University Health Network.

The Emili and Gramolini teams combined strengths to dig deep into the heart muscle and compare changes in protein signalling networks that are active in healthy and DCM hearts. Proteins are the end products of genes, and they do most of the work in cells - for example, heart growth during development is controlled by complex signalling networks between thousands of different proteins. Their activity is often regulated by phosphorylation - a biochemical reaction where a phosphate group is added onto a protein to make it more, or less, active, or to change its position in the cell, or to mark it for destruction. By scanning the patterns of protein phosphorylation, they were able to study how sick hearts ramp up, or dampen, entire protein signalling pathways - thus becoming vulnerable to heart failure.

"We decided to measure global protein phosphorylation in heart tissue to get a sense for how signalling pathways differ between DCM and normal hearts," said Dr. Uros Kuzmanov, who spearheaded the project as a postdoctoral research fellow in both Emili and Gramolini labs. No such study had been attempted on such a scale in the past.

As a stand in for the human disease, Kuzmanov used mice that carry a mutation, akin to one found in human patients, that makes them develop all signs of DCM. To get a better understanding of how the disease begins, the teams collected heart samples from young adult healthy and mutant mice, at a time when their heart muscles just began to stretch, for a side-by-side analysis. The researchers then ground the heart tissue to remove the proteins, which were fed into a mass spectrometer to be counted.

Based on the changes in the levels of thousands of phosphorylated proteins, the researchers uncovered hundreds of signalling pathways that went off course in DCM hearts. This is the first comprehensive map of molecular signaling events - including those unexpected - that go awry in heart failure.

Next, the teams will carry out similar analysis in human tissue. If, as expected, they can detect similarly robust changes in the same signalling pathways in patients' hearts, then the human map could help scientists nail down promising new drug targets or biomarkers for early detection.

"We expect to be able to detect specific changes in signalling pathways in different cardiac patients," said Kuzmanov. "And our approach is not limited to the DCM -- it could be applied to all heart disease."
-end-


University of Toronto

Related Heart Failure Articles:

New hope for treating heart failure
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Activated T-cells drive post-heart attack heart failure
Chronic inflammation after a heart attack can promote heart failure and death.
ICU care for COPD, heart failure and heart attack may not be better
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Tissue engineering advance reduces heart failure in model of heart attack
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Smoking may lead to heart failure by thickening the heart wall
Smokers without obvious signs of heart disease were more likely than nonsmokers and former smokers to have thickened heart walls and reduced heart pumping ability.
After the heart attack: Injectable gels could prevent future heart failure (video)
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
Heart failure after first heart attack may increase cancer risk
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
Scientists use 'virtual heart' to model heart failure
A team of researchers have created a detailed computational model of the electrophysiology of congestive heart failure, a leading cause of death.
Increase in biomarker linked with increased risk of heart disease, heart failure, death
In a study published online by JAMA Cardiology, Elizabeth Selvin, Ph.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues examined the association of six-year change in high-sensitivity cardiac troponin T with incident coronary heart disease, heart failure and all-cause mortality.
1 in 4 patients develop heart failure within 4 years of first heart attack
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.

Related Heart Failure Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".